During tRNA maturation in yeast, aberrant pre-tRNAs are targeted for 3 ′ ′ ′ ′ ′ -5 ′ ′ ′ ′ ′ degradation by the nuclear surveillance pathway, and aberrant mature tRNAs are targeted for 5 ′ ′ ′ ′ ′ -3 ′ ′ ′ ′ ′ degradation by the rapid tRNA decay (RTD) pathway. RTD is catalyzed by the 5 ′ ′ ′ ′ ′ -3 ′ ′ ′ ′ ′ exonucleases Xrn1 and Rat1, which act on tRNAs with an exposed 5 ′ ′ ′ ′ ′ end due to the lack of certain body modifications or the presence of destabilizing mutations in the acceptor stem, T-stem, or tRNA fold. RTD is inhibited by mutation of MET22, likely due to accumulation of the Met22 substrate adenosine 3 ′ ′ ′ ′ ′ ,5 ′ ′ ′ ′ ′ bis-phosphate, which inhibits 5 ′ ′ ′ ′ ′ -3 ′ ′ ′ ′ ′ exonucleases. Here we provide evidence for a new tRNA quality control pathway in which intron-containing pre-tRNAs with destabilizing mutations in the anticodon stem are targeted for Met22-dependent pre-tRNA decay (MPD). Multiple SUP4 οc anticodon stem variants that are subject to MPD each perturb the bulge-helix-bulge structure formed by the anticodon stem-loop and intron, which is important for splicing, resulting in substantial accumulation of end-matured unspliced pre-tRNA as well as pre-tRNA decay. Mutations that restore exon-intron structure commensurately reduce pre-tRNA accumulation and MPD. The MPD pathway can contribute substantially to decay of anticodon stem variants, since pre-tRNA decay is largely suppressed by removal of the intron or by restoration of exon-intron structure, each also resulting in increased tRNA levels. The MPD pathway is general as it extends to variants of tRNA Tyr(GUA) and tRNA Ser(CGA) . These results demonstrate that the integrity of the anticodon stem-loop and the efficiency of tRNA splicing are monitored by a quality control pathway.